Pulse Biosciences to Participate in the H.C. Wainwright Global Investment Conference
September 01 2020 - 4:05PM
Business Wire
Pulse Biosciences, Inc. (Nasdaq: PLSE) a novel bioelectric
medicine company progressing Nano-Pulse Stimulation™ (NPS™)
technology, today announced plans to virtually participate in the
upcoming H.C. Wainwright Global Investment Conference.
Management is scheduled to present Tuesday, September 15, 2020
at 1:30pm ET. Interested parties may access a live and recorded
webcast on the “Investors” section of the Company’s website at
www.pulsebiosciences.com.
About Pulse Biosciences® Pulse Biosciences is a novel
bioelectric medicine company committed to health innovation that
has the potential to improve and extend the lives of patients. If
cleared, the CellFX® System will be the first commercial product to
harness the distinctive advantages of the Company’s proprietary
Nano-Pulse Stimulation™ (NPS™) technology to treat a variety of
applications for which an optimal solution remains unfulfilled.
Nano-Pulse Stimulation technology delivers nano-second pulses of
electrical energy to non-thermally clear cells while sparing
adjacent non-cellular tissue. Subject to regulatory approval, the
initial commercial use of the CellFX System is expected to address
a broad range of dermatologic conditions that share high demand
among patients and practitioners for improved and durable aesthetic
outcomes. Designed as a multi-application platform, the CellFX
System is intended to offer customer value with a utilization-based
revenue model across an expanding spectrum of clinical
applications. To learn more please visit
www.pulsebiosciences.com.
Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS and the
stylized logos are among the trademarks and/or registered
trademarks of Pulse Biosciences, Inc. in the United States and
other countries.
Caution: Pulse Biosciences’ CellFX System and Nano-Pulse
Stimulation technology are for investigational use only.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200901005997/en/
Investors: Pulse Biosciences Sandra Gardiner, EVP and CFO
510.241.1077 IR@pulsebiosciences.com or Gilmartin Group Philip Trip
Taylor 415-937-5406 philip@gilmartinir.com
Media: Tosk Communications Nadine D. Tosk 504.453.8344
press@pulsebiosciences.com
Pulse Biosciences (NASDAQ:PLSE)
Historical Stock Chart
From Apr 2024 to May 2024
Pulse Biosciences (NASDAQ:PLSE)
Historical Stock Chart
From May 2023 to May 2024